These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 368997)

  • 1. [Study of an inhibitor of platelet aggregation [prostacycline] derived from rat arterial wall (author's transl)].
    García-Conde J; Merino J; Benet I
    Sangre (Barc); 1978; 23(5):526-34. PubMed ID: 368997
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of prostacycline aerosol on the activity of blood platelets and lungs].
    Szczeklik A; Gryglewski R; Nizankowski R; Nizankowska E; Musiał J
    Pol Tyg Lek; 1979 Jul; 34(31):1225-7. PubMed ID: 388372
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of platelet aggregation inhibitor in nephrodialysis].
    Armani U; Piana A; Griffanti-Bartoli F; Altomonte F
    Arch Maragliano Patol Clin; 1979; 35(2):63-5. PubMed ID: 400622
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
    Herman AG
    Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibitory effect of 2-(4-(2-imidazo(1,2-a)pyridyl)phenyl) propionic acid (miroprofen) on platelet aggregation and prostaglandin I2 generation (author's transl)].
    Mikashima H; Goto K
    Yakugaku Zasshi; 1982 Jan; 102(1):99-103. PubMed ID: 7045328
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current state of our knowledge about prostaglandins].
    Markov KhM
    Patol Fiziol Eksp Ter; 1979; (5):3-15. PubMed ID: 228228
    [No Abstract]   [Full Text] [Related]  

  • 10. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arachidonic acid metabolism and platelet function in diabetics (author's transl)].
    Amado Señaris JA; Garcia-Conde Bru J; Merino Sanchez J; Benet Monforte I
    Sangre (Barc); 1981; 26(3):351-9. PubMed ID: 6794160
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostacyclin in physiology and pathophysiology.
    Vane JR; Bunting S; Moncada S
    Int Rev Exp Pathol; 1982; 23():161-207. PubMed ID: 6806207
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenetic mechanisms of platelet hyperaggregation in diabetics (author's transl)].
    Amado Señars JA; García-Conde Bru J; Merino Sánchez J; Benet Monforte I
    Sangre (Barc); 1981; 26(4):409-16. PubMed ID: 7027491
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system].
    Gabrielian ES; Akopov SE; Badzhinian SA
    Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016
    [No Abstract]   [Full Text] [Related]  

  • 16. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
    Hemker DP; Shebuski RJ; Aiken JW
    J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of prostaglandins in platelet-vessel wall interaction.
    Bourgain RH; Andries R; Finne E
    Arch Int Pharmacodyn Ther; 1979 May; 239(1):161-3. PubMed ID: 384949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostacyclin versus regional heparinisation during haemodialysis (author's transl)].
    Hory B; Saunier F; Roy C; Renevier A; Kieffer Y; Saint-Hillier Y; Perol C
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2393-7. PubMed ID: 7050907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular action of drugs affecting platelet functions (author's transl)].
    Verstraete M
    Rev Med Brux; 1981 Mar; 2(3):301-8. PubMed ID: 6262895
    [No Abstract]   [Full Text] [Related]  

  • 20. [Platelet aggregation and endogenous prostaglandins and thromboxane (author's transl)].
    Katori M
    No Shinkei Geka; 1980 Aug; 8(8):717-22. PubMed ID: 6999371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.